PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.
Blood
; 139(4): 523-537, 2022 01 27.
Article
in En
| MEDLINE
| ID: mdl-35084470
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Purines
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Immunotherapy, Adoptive
/
Phosphoinositide-3 Kinase Inhibitors
/
Isoquinolines
Limits:
Animals
/
Humans
Language:
En
Journal:
Blood
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: